AUSTRALIA'S #1 ONLINE CPD EDUCATION PLATFORM

This year we celebrate the centenary of the modern era of diabetology which began with the discovery of insulin in 1921.

This clinical audit aims to improve the management of patients with iron deficiency following oral or IV iron supplementation.

This module aims to educate GPs on the late effects of polio and how to identify and support affected patients.
This module aims to improve GP confidence in managing early schizophrenia, including identifying and managing negative symptoms to reduce disability for their patients.

This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.

This education explores how to identify patients at elevated risk of cancer due to Lynch syndrome, and provides an overview of how Family Cancer Clinics can assist these patients through genetic testing and...

Managing epilepsy in older people: Optimising outcomes in general practice

Epilepsy is a common problem for older adults, and has a greater impact in older people compared to younger populations. This module describes key differences between the causes and presentation of epilepsy in older versus younger people, as well as special considerations for prescribing antiseizure drugs for older people. This two-hour activity contains a online learning module as well as a patient review exercise involving preparation of a GP Management Plan for a patient.

T2D injectables: 1. Intensifying to first injectable therapy in uncomplicated type 2 diabetes

This education module focuses on a case study of an uncomplicated patient with type 2 diabetes, and the process of intensifying to first injectable therapy. Expert video commentary throughout the module helps step the participant through the decision cycle from the ADA/EASD consensus guidelines for T2D. This module also includes Australian recommendations for patients fasting during Ramadan.

T2D injectables: 2. Intensifying to first injectable therapy in patients with ASCVD risk

In this education module, the participant will work through a case study of a type 2 diabetes patient with ASCVD risk factors. The case study uses the decision cycle from the ADA/EASD consensus guidelines for T2D, and features expert video commentary. The module also discusses patient-related concerns leading to clinical inertia, including useful management decisions when faced with this issue.

T2D injectables: 3. Intensifying to first injectable therapy in patients with established ASCVD

This education module takes a case-study based look at the management of a type 2 diabetes patient with established ASCVD. Featuring expert video commentary, participants will use the decision cycle from the ADA/EASD consensus guidelines for T2D to work through a hypothetical case study. This module also discusses GP-related causes of clinical inertia, as well as additional patient factors such as obesity, low health literacy and diabetes distress.

Pages